September 15, 2019

Eli Lilly Paid Mass Shooting Victims Hush Money in Prozac Lawsuit

The “norm and practice” of Pharmaceutical companies is to vehemently deny the most serious adverse side effects

Read More
Eli Lilly Paid Mass Shooting Victims Hush Money in Prozac Lawsuit

October 7, 2012

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

IV. What Do We Get for All That Money? According to the Kaiser Foundation:[1] The number of

Read More
America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

May 9, 2012

Harvard To Be Tried for Alzheimer’s Research Fraud

The case involves the largest Alzheimer’s disease [AD] research grants awarded by the National Institutes of Health

Read More
Harvard To Be Tried for Alzheimer’s Research Fraud

April 11, 2012

Why Eli Lilly’s Alzheimer’s Imaging Test- Amyvid- Is NO Breakthrough

The focus, in this instance, is not a therapeutic intervention, but rather a test using a radioactive

Read More
Why Eli Lilly’s Alzheimer’s Imaging Test- Amyvid- Is NO Breakthrough

April 14, 2011

Private Foundations’ Conflicts of Interest Revealed

Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?  by David Stuckler, Sanjay

Read More
Private Foundations’ Conflicts of Interest Revealed

April 7, 2011

SSRI Antidepressants Linked to Breast Cancer

 “Reviewing the evidence is a critical public health issue in light of the increasing prevalence of antidepressant

Read More
SSRI Antidepressants Linked to Breast Cancer

March 25, 2011

Jury Finds Johnson & Johnson Violated Consumer Protection Law

Johnson & Johnson lost another case involving its outrageously deceptive marketing of the antipsychotic, Risperdal. This time,

Read More
Jury Finds Johnson & Johnson Violated Consumer Protection Law

March 7, 2011

This Year Alone, Drug Industry To Lose $50 billion

At long last Big Pharma’s ill-begotten profits are slated to take a major financial hit. * This

Read More
This Year Alone, Drug Industry To Lose $50 billion

January 21, 2011

FDA to Approve PET Scan for Alzheimer’s?

On January 19, 2011, the FDA expressed concerns about an Alzheimer’s brain imaging PET scan that is

Read More
FDA to Approve PET Scan for Alzheimer’s?

January 14, 2011

The Truth Wears Off

The excerpts from The New Yorker (below) may be read as a companion piece to the Atlantic

Read More
The Truth Wears Off

January 5, 2011

Astellas Pharma Sues Prescrire, a Medical Journal

Le Figaro reports (below French with English translation by Professor David Cohen*) that Astellas Pharma, the Japanese

Read More
Astellas Pharma Sues Prescrire, a Medical Journal

December 23, 2010

1991-2010 Enormous Scale of Pharma Criminal Fraud Settlements

 A report by Public Citizen documents the enormous scale of pharmaceutical industry lawless activities during the past

Read More
1991-2010 Enormous Scale of Pharma Criminal Fraud Settlements

October 3, 2010

Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

A New York Times report (below) reviews what has been accomplished by multiple civil and criminal lawsuits

Read More
Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

September 16, 2010

NY Times Corrects Gina Kolata Re: Alzheimer’s

Today, five weeks after publishing a grossly dis-informative front-page report by Gina Kolata, "Spinal-Fluid Test Finds Proteins

Read More
NY Times Corrects Gina Kolata Re: Alzheimer’s